Daily non-political popular news in brief.

New alzheimer's drug shows promise in clinical trial

The only drugs currently available for Alzheimer's patients are those that alleviate symptoms, but a team of scientists led by Paul Aisen, MD, director of the Memory Disorders program at Georgetown University Medical Center, is testing a new class of drugs that actually target the molecule believed to cause the disease.

Read more »

Keywords: alzheimer, drug, shows, promise, clinical, trial, show

« Previous | Next »

Similar news on "New alzheimer's drug shows promise in clinical trial":

1. New drug combination shows promise for African sleeping sickness
   11-06-2007 · EurekAlert!
   A small clinical trial in Uganda, conducted within a long-established Medecins Sans Frontieres treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation. Despite the low sample size, the findings were promising: no cases of treatment failure, no treatment terminations, and no HAT- or treatment-related deaths.
   Similar news · Read more »
   
2. Experimental MS drug shows promise, offers new window on disease
   02-13-2008 · EurekAlert!
   A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
   Similar news · Read more »
   
3. Minimally invasive device shows promise in treating female urinary incontinence
   05-22-2007 · EurekAlert!
   A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
   Similar news · Read more »
   
4. Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
   06-02-2007 · EurekAlert!
   An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a phase II clinical trial at the University of Texas M. D. Anderson Cancer Center.
   Similar news · Read more »
   
5. New drug shows promise in treatment of advanced thyroid cancer
   06-04-2007 · EurekAlert!
   The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported June 3 at the annual meeting of the American Society for Clinical Oncology in Chicago.
   Similar news · Read more »
   
6. Researchers propose reason for severe side-effects of Northwick Park clinical trial
   01-25-2007 · EurekAlert!
   A possible reason why the Northwick Park clinical trial of the drug TGN1412 in the UK caused multiple organ failure in human volunteers is revealed in research presented today at a conference near Paris. The research shows that stimulating the molecule CD28 on cells that mediate the immune response, known as T cells, can have an adverse effect if these immune cells have been activated and altered by infection or illness in the past.
   Similar news · Read more »
   
7. UCSF brain tumor vaccine trial shows promising results
   04-16-2007 · EurekAlert!
   A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
   Similar news · Read more »
   
8. VEGF Trap shows activity in patients with advanced ovarian cancer
   06-02-2007 · EurekAlert!
   Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents. The findings, which are being presented today at the American Society of Clinical Oncology’s annual meeting, may indicate a role for this targeted therapy in women with ovarian cancer who have exhausted all other options.
   Similar news · Read more »
   
9. Novel MS drug shows promise in 2 lethal leukemias
   08-28-2007 · EurekAlert!
   A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
   Similar news · Read more »
   
10. Gene therapy for erectile dysfunction shows promise in clinical trial
    12-01-2006 · EurekAlert!
    The first human trial of gene transfer therapy for erectile dysfunction (ED) indicates that gene therapy that lasts for months and eliminates the patient's need for on-demand drugs (such as Viagra and Cialis), could become the future treatment of choice for this common problem, according to a paper in the most recent issue of Human Gene Therapy.
    Similar news · Read more »